・Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India ・Tirzepatide is used to manage type 2 diabetes and chronic weight issues in adults ・The stock has outperformed the ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey BENGALURU (Reuters) ...

Cipla Ltd. today launched its nationwide awareness initiative, #InhaleTheChange, aimed at encouraging better insulin adherence through empowerment, and destigmatization. These efforts reflect Cipla’s ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") and Wellthy Therapeutics Private Limited ("Wellthy Therapeutics") today announced that they have entered into a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BENGALURU (Reuters) - India's Cipla has signed a deal with Eli Lilly to sell and distribute two of the U.S. drugmaker's best-selling diabetes treatments in the country, the companies said in a joint ...

BENGALURU (Reuters) – India’s Cipla has signed a deal with Eli Lilly to sell and distribute two of the U.S. drugmaker’s best-selling diabetes treatments in the country, the companies said in a joint ...